The Study of SHR7390 in Combination With SHR-1210 and SHR3162 in Patients With Advanced Solid Tumors

NCT03182673 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

31

Enrollment

INDUSTRY

Sponsor class

Stopped Sponsor R \& D Strategy Adjustment

Conditions

Solid Tumor

Interventions

DRUG: SHR7390
BIOLOGICAL: SHR-1210
DRUG: SHR3162

Sponsor

Jiangsu HengRui Medicine Co., Ltd.